Abraxane 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQS7Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,019
Award facts
- Contract value 100% obligated
- $18,019.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,019.13 to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication used in cancer treatment. The award, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award of this pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. The firm's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements through open competition, positioning it as a primary vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQS7Z?
SPE2DR26FQS7Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FQS7Z worth?
The government has obligated $18,019 on SPE2DR26FQS7Z.
Is contract SPE2DR26FQS7Z an order under another contract?
Yes. SPE2DR26FQS7Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS7Z competed?
The extent of competition for SPE2DR26FQS7Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award